Molecular Psychiatry

Article	Citations
Reply to “Comment on: What genes are differentially expressed in individuals with schizophrenia? A systematic review”	1502
Activation of β2-adrenergic receptors prevents AD-type synaptotoxicity via epigenetic mechanisms	798
Electric field distribution models in ECT research	382
Loss of liver X receptor β in astrocytes leads to anxiety-like behaviors via regulating synaptic transmission in the medial prefrontal cortex in mice	267
Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settings	246
Network state dynamics underpin basal craving in a transdiagnostic population	186
The universe is asymmetric, the mouse brain too	185
Respiratory disease in people with bipolar disorder: a systematic review and meta-analysis	182
Multi-polygenic score prediction of mathematics, reading, and language abilities independent of general cognitive ability	177
Neurocognitive profiles of 22q11.2 and 16p11.2 deletions and duplications	174
How to (not) decide about the motor vs psychomotor origin of psychomotor disturbances in depression	172
Mediating and moderating effects of plasma proteomic biomarkers on the association between poor oral health problems and brain white matter microstructural integrity: the UK Biobank study	166
Targeting high-affinity nicotinic receptors protects against the functional consequences of β-amyloid in mouse hippocampus	161
Abatacept inhibits Th17 differentiation and mitigates α-synuclein-induced dopaminergic dysfunction in mice	158
Comment on “Perception of social inclusion/exclusion and response inhibition in adolescents with past suicide attempt: a multidomain task-based fMRI study.” by Gifuni et al.	151
Microglial type I interferon signaling mediates chronic stress-induced synapse loss and social behavior deficits	150
The multifaceted role of mitochondria in autism spectrum disorder	146
Risk of suicide and all-cause death in patients with mental disorders: a nationwide cohort study	145
Frequency-specific and state-dependent neural responses to brain stimulation	144
How does oxytocin modulate human behavior?	120
Are we getting closer to offering deep brain stimulation for treatment-resistant depression in clinical practice?	109
Novel epigenetic molecular therapies for imprinting disorders	105
Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders	103
Although serotonin is not a major player in depression, its precursor is	103
A causal association of ANKRD37 with human hippocampal volume	95

Cross-sectional and longitudinal neuroanatomical profiles of distinct clinical (adaptive) outcomes in autism	91
Microbial infection promotes amyloid pathology in a mouse model of Alzheimer’s disease via modulating γ-secretase	90
Perifornical area Urocortin-3 neuronal activation levels in response to foreign pups depends on physiological context	90
Rare copy number variation in posttraumatic stress disorder	89
Heparin treatment is associated with a delayed diagnosis of Alzheimer’s dementia in electronic health records from two large United States health systems	89
Divergent projections of the prelimbic cortex mediate autism- and anxiety-like behaviors	88
Top-down regulation of motivated behaviors via lateral septum sub-circuits	83
Cortical profiles of numerous psychiatric disorders and normal development share a common pattern	83
The acute phase protein lactoferrin is a key feature of Alzheimer’s disease and predictor of Aβ burden through induction of APP amyloidogenic processing	83
Sustained TNF signaling is required for the synaptic and anxiety-like behavioral response to acute stress	83
LHPP, a risk factor for major depressive disorder, regulates stress-induced depression-like behaviors through its histidine phosphatase activity	82
Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses	79
Sex differences in methylphenidate-induced dopamine increases in ventral striatum	78
The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders	77
Self-management with alcohol over lifespan: psychological mechanisms, neurobiological underpinnings, and risk assessment	77
Aberrant impulse control circuitry in obesity	76
Caspase-cleaved tau is senescence-associated and induces a toxic gain of function by putting a brake on axonal transport	76
The effects of stimulant dose and dosing strategy on treatment outcomes in attention-deficit/hyperactivity disorder in children and adolescents: a meta-analysis	76
Cognitive performance protects against Alzheimer’s disease independently of educational attainment and intelligence	75
Multi-ancestry genome-wide gene–sleep interactions identify novel loci for blood pressure	72
Dopamine transporter blockade during adolescence increases adult dopamine function, impulsivity, and aggression	72
Targeted therapy of cognitive deficits in fragile X syndrome	71
Rare coding variants as risk modifiers of the 22q11.2 deletion implicate postnatal cortical development in syndromic schizophrenia	70
Expanding the heuristic neurocircuit-based taxonomy to guide treatment for OCD: reply to the commentary “Probing the genetic and molecular correlates of connectome alterations in obsessive-compulsive	69
The effects of methylphenidate and atomoxetine on Drosophila brain at single-cell resolution and potential drug repurposing for ADHD treatment	67
Ca2+-permeable AMPA receptors set the threshold for retrieval of drug memories	66
Brain-specific deletion of GIT1 impairs cognition and alters phosphorylation of synaptic protein networks implicated in schizophrenia susceptibility	66
Trans-ancestry epigenome-wide association meta-analysis of DNA methylation with lifetime cannabis use	65
Assessment of early neurocognitive functioning increases the accuracy of predicting chronic PTSD risk	65
Implications of parental stress on worsening of behavioral problems in children with autism during COVID-19 pandemic: “the spillover hypothesis”	65
Whole-brain resting-state connectivity underlying impaired inhibitory control during early versus longer-term abstinence in cocaine addiction	64
Diversity of mechanism of action of psychotropic drugs in their anti-COVID-19 properties	64
Newly identified structures of trace-amine associated receptor-1 (TAAR1) will aid discovery of next generation neuropsychiatric drugs	64
The orphan receptor GPR88 controls impulsivity and is a risk factor for Attention-Deficit/Hyperactivity Disorder	63
In vivo tractography of human locus coeruleus—relation to 7T resting state fMRI, psychological measures and single subject validity	63
Neurotrophin receptor activation rescues cognitive and synaptic abnormalities caused by hemizygosity of the psychiatric risk gene Cacna1c	63
A new suspect in the unsolved case of neuroinflammation in schizophrenia	63
Development of opioid-induced hyperalgesia depends on reactive astrocytes controlled by Wnt5a signaling	63
Resting mononuclear cell NR3C1 and SKA2 expression levels predict blunted cortisol reactivity to combat training stress among elite army cadets exposed to childhood adversity	62
Internal capsule microstructure mediates the relationship between childhood maltreatment and PTSD following adulthood trauma exposure	62
Transcriptomics analysis of human iPSC-derived dopaminergic neurons reveals a novel model for sporadic Parkinson’s disease	61
An increased copy number of glycine decarboxylase (GLDC) associated with psychosis reduces extracellular glycine and impairs NMDA receptor function	61
Gestational epigenetic age and ADHD symptoms in childhood: a prospective, multi-cohort study	61
Sex dimorphism controls dysbindin-related cognitive dysfunctions in mice and humans with the contribution of COMT	60
Rare variants implicate NMDA receptor signaling and cerebellar gene networks in risk for bipolar disorder	60
Age, sex, and apolipoprotein E isoform alter contextual fear learning, neuronal activation, and baseline DNA damage in the hippocampus	60
Divergent time-varying connectivity of thalamic sub-regions characterizes clinical phenotypes and cognitive status in multiple sclerosis	59
Aβ1-6A2V(D) peptide, effective on Aβ aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury	59
A burden of rare copy number variants in obsessive-compulsive disorder	59
A prediction model for electroconvulsive therapy effectiveness in patients with major depressive disorder from the Dutch ECT Consortium (DEC)	58

Cannabidiol ameliorates cognitive decline in 5×FAD mouse model of Alzheimer’s disease through potentiating the function of extrasynaptic glycine receptors	58
Immunoglobulin genes expressed in lymphoblastoid cell lines discern and predict lithium response in bipolar disorder patients	58
Effects of sleep on the glymphatic functioning and multimodal human brain network affecting memory in older adults	57
Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome	57
Whole exome sequencing identified six novel genes for depressive symptoms	56
Methylome-wide association study of anxiety disorders	55
Shared genetic basis between reproductive behaviors and anxiety-related disorders	55
Tractography-based versus anatomical landmark-based targeting in vALIC deep brain stimulation for refractory obsessive-compulsive disorder	54
An IGFBP2-derived peptide promotes neuroplasticity and rescues deficits in a mouse model of Phelan-McDermid syndrome	54
Time will tell. Reply to “Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al.” by Chen et al.	53
Trans-genetic effects of circular RNA expression quantitative trait loci and potential causal mechanisms in autism	53
Phosphoproteomic of the acetylcholine pathway enables discovery of the PKC-β-PIX-Rac1-PAK cascade as a stimulatory signal for aversive learning	53
School achievement in adolescence and the risk of mental disorders in early adulthood: a Finnish nationwide register study	53
Genome-wide significant risk loci for mood disorders in the Old Order Amish founder population	53
Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission	52
Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis	52
Resting-state EEG dynamic functional connectivity distinguishes non-psychotic major depression, psychotic major depression and schizophrenia	51
Developmental loss of ErbB4 in PV interneurons disrupts state-dependent cortical circuit dynamics	51
In vivo study sheds new light on the dendritic spine pathology hypothesis of schizophrenia	50
Rare tandem repeat expansions associate with genes involved in synaptic and neuronal signaling functions in schizophrenia	50
Inactivation of hypocretin receptor-2 signaling in dopaminergic neurons induces hyperarousal and enhanced cognition but impaired inhibitory control	50
Psychedelics and ketamine are a symptom of psychiatry’s woes, not a cure	50
Nurture outpaces nature: fostering with an attentive mother alters social dominance in a mouse model of stress sensitivity	50
Prion-like properties of the mutant huntingtin protein in living organisms: the evidence and the relevance	50
Microglia shape AgRP neuron postnatal development via regulating perineuronal net plasticity	50
Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis	50
Structural gray matter differences in Problematic Usage of the Internet: a systematic review and meta-analysis	49
Mechanisms underlying capsulotomy for refractory obsessive-compulsive disorder: neural correlates of negative affect processing overlap with deep brain stimulation targets	49
Infections and neuropsychiatric disorders: new studies document pathways to prevention and treatment	49
Amygdala DCX and blood Cdk14 are implicated as cross-species indicators of individual differences in fear, extinction, and resilience to trauma exposure	49
From multivariate methods to an AI ecosystem	49
The GABAergic system in Alzheimer’s disease: a systematic review with meta-analysis	48
Alternative splicing in mouse brains affected by psychological stress is enriched in the signaling, neural transmission and blood-brain barrier pathways	48
SIRT1 deficiency increases O-GlcNAcylation of tau, mediating synaptic tauopathy	48
Angiogenic gene networks are dysregulated in opioid use disorder: evidence from multi-omics and imaging of postmortem human brain	48
Reducing alcohol and/or cocaine-induced reward and toxicity via an epidermal stem cell-based gene delivery platform	47
Structure-function relationships of the disease-linked A218T oxytocin receptor variant	47
Integration of peripheral transcriptomics, genomics, and interactomics following trauma identifies causal genes for symptoms of post-traumatic stress and major depression	47
Resting-state functional connectivity changes in older adults with sleep disturbance and the role of amyloid burden	47
Sex differences in plasma p-tau181 associations with Alzheimer’s disease biomarkers, cognitive decline, and clinical progression	46
What next for eating disorder genetics? Replacing myths with facts to sharpen our understanding	46
Mapping the cortico-striatal transcriptome in attention deficit hyperactivity disorder	46
Biogeography of the large intestinal mucosal and luminal microbiome in cynomolgus macaques with depressive-like behavior	46
The serotonin theory of depression	46
Cognitive deficits, clinical variables, and white matter microstructure in schizophrenia: a multisite harmonization study	46
In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach	46
Effects of deep brain stimulation on cognitive functioning in treatment-resistant depression: a systematic review and meta-analysis	45
The role of PPAR-γ in memory deficits induced by prenatal and lactation alcohol exposure in mice	45
Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnoses	45
The need for a reliable oxytocin assay	44
Hippocampal neurogenesis promotes preference for future rewards	44
Neurite outgrowth deficits caused by rare PLXNB1 mutation in pediatric bipolar disorder	44
Maternal autoantibody profiles as biomarkers for ASD and ASD with co-occurring intellectual disability	44
Behaviorally penetrant, anomalous dopamine efflux exposes sex and circuit dependent regulation of dopamine transporters	44
Using induced pluripotent stem cells to investigate human neuronal phenotypes in 1q21.1 deletion and duplication syndrome	44
Melatonin: A potential nighttime guardian against Alzheimer’s	43
Adherence to a psychobiotic diet stabilizes the microbiome and reduces perceived stress: plenty of food for thought	43
Alzheimer’s disease biomarkers and their current use in clinical research and practice	43
Psilocybin increases emotional empathy in patients with major depression	43
Evidence for thyroid hormone regulation of amygdala-dependent fear-relevant memory and plasticity	42
Genetic analyses point to alterations in immune-related pathways underpinning the association between psychiatric disorders and COVID-19	42
Influenza A virus during pregnancy disrupts maternal intestinal immunity and fetal cortical development in a dose- and time-dependent manner	42
Integration of valence and conflict processing through cellular-field interactions in human subgenual cingulate during emotional face processing in treatment-resistant depression	41
Brain regions susceptible to alpha-synuclein spreading	41
Dimensional Affective Sensitivity to Hormones across the Menstrual Cycle (DASH-MC): A transdiagnostic framework for ovarian steroid influences on psychopathology	41
Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway	40
Electroconvulsive therapy, electric field, neuroplasticity, and clinical outcomes	40
EF1α-associated protein complexes affect dendritic spine plasticity by regulating microglial phagocytosis in Fmr1 knock-out mice	40
Anti-depressive-like behaviors of APN KO mice involve Trkb/BDNF signaling related neuroinflammatory changes	40
Allosteric inhibition of NMDA receptors by low dose ketamine	40
A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia	40
Addiction biotypes: a paradigm shift for future treatment strategies?	39
Ucp2-dependent microglia-neuronal coupling controls ventral hippocampal circuit function and anxiety-like behavior	39
GWAS-identified bipolar disorder risk allele in the FADS1/2 gene region links mood episodes and unsaturated fatty acid metabolism in mutant mice	39
Astrocytes in the adult dentate gyrus—balance between adult and developmental tasks	39
Neuronal network activity and connectivity are impaired in a conditional knockout mouse model with PCDH19 mosaic expression	39
Deficiency of FRMD5 results in neurodevelopmental dysfunction and autistic-like behavior in mice	39
Human iN neuronal model of schizophrenia displays dysregulation of chromogranin B and related neuropeptide transmitter signatures	39
PPARα and PPARγ are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice	39
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials	38

Insulin-like growth factor I mitigates post-traumatic stress by inhibiting AMP-kinase in orexin neurons	38
Evolution of genetic networks for human creativity	38
Positive modulation of N-methyl-D-aspartate receptors in the mPFC reduces the spontaneous recovery of fear	38
Genetics of environmental sensitivity and its association with variations in emotional problems, autistic traits, and wellbeing	38
SIRT1 in the BNST modulates chronic stress-induced anxiety of male mice via FKBP5 and corticotropin-releasing factor signaling	38
Medial prefrontal cortex Notch1 signalling mediates methamphetamine-induced psychosis via Hes1-dependent suppression of GABAB1 receptor expression	37
Putting the “mental” back in “mental disorders”: a perspective from research on fear and anxiety	37
Unconsidered issues of measurement noninvariance in biological psychiatry: A focus on biological phenotypes of psychopathology	37
Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study	37
Changes in cerebral connectivity and brain tissue pulsations with the antidepressant response to an equimolar mixture of oxygen and nitrous oxide: an MRI and ultrasound study	37
HuM195 and its single-chain variable fragment increase Aβ phagocytosis in microglia via elimination of CD33 inhibitory signaling	37
The role of polyunsaturated fatty acids in the neurobiology of major depressive disorder and suicide risk	36
Inflammation and depression in young people: a systematic review and proposed inflammatory pathways	36
State-specific alterations in the neural computations underlying inhibitory control in women remitted from bulimia nervosa	36
Circadian rhythm disruptions associated with opioid use disorder in synaptic proteomes of human dorsolateral prefrontal cortex and nucleus accumbens	36
Digital phenotyping in molecular psychiatry—a missed opportunity?	36
Functional connectivity of the amygdala subnuclei in various mood states of bipolar disorder	35
The pathogenic APP N-terminal Val225Ala mutation alters tau protein liquid-liquid phase separation and exacerbates synaptic damage	35
Integrating genome-wide information and wearable device data to explore the link of anxiety and antidepressants with pulse rate variability	35
Systems biological assessment of altered cytokine responses to bacteria and fungi reveals impaired immune functionality in schizophrenia	35
Structural deviations of the posterior fossa and the cerebellum and their cognitive links in a neurodevelopmental deletion syndrome	35
Hippocampal neurogenesis in adult primates: a systematic review	35
Maternal COVID-19 infection associated with offspring neurodevelopmental disorders	35
Central amygdala corticotropin-releasing factor neurons promote hyponeophagia but do not control alcohol drinking in mice	35
Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study	35
Complex functional phenotypes of NMDA receptor disease variants	35
Integrative analysis of genetics, epigenetics and RNA expression data reveal three susceptibility loci for smoking behavior in Chinese Han population	34
Barriers and solutions to the adoption of translational tools for computational psychiatry	34
Gene – maltreatment interplay in adult ADHD symptoms: main role of a gene–environment correlation effect in a Brazilian population longitudinal study	34
Diffusion imaging genomics provides novel insight into early mechanisms of cerebral small vessel disease	34
Bipolar disorder-iPSC derived neural progenitor cells exhibit dysregulation of store-operated Ca2+ entry and accelerated differentiation	34
Disease-specific alterations in central fear network engagement during acquisition and extinction of conditioned interoceptive fear in inflammatory bowel disease	34
Causal and common risk pathways linking childhood maltreatment to later intimate partner violence victimization	34
Monoallelic loss-of-function variants in GSK3B lead to autism and developmental delay	34
Life-course neighbourhood deprivation and brain structure in older adults: the Lothian Birth Cohort 1936	34
Sex differences in trajectories of cortical development in autistic children from 2–13 years of age	34
Medication effects on developmental sterol biosynthesis	33
Influences of dopaminergic system dysfunction on late-life depression	33
Molecular genetics of cocaine use disorders in humans	33
MEK1/2 inhibition rescues neurodegeneration by TFEB-mediated activation of autophagic lysosomal function in a model of Alzheimer’s Disease	33
Dynamic and progressive changes in thalamic functional connectivity over the first five years of psychosis	33
Real-world effectiveness of long-acting injectable antipsychotic treatments in a nationwide cohort of 12,373 patients with schizophrenia-spectrum disorders	33
The neurobiology of duration of untreated psychosis: a comprehensive review	33
Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation	33
Prefrontal cortex astroglia modulate anhedonia-like behavior	32
Schizophrenia is associated with altered DNA methylation variance	32
Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential	32
Relevance of interactions between dopamine and glutamate neurotransmission in schizophrenia	32
Preventing incubation of drug craving to treat drug relapse: from bench to bedside	32
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability	32
The serotonin theory of depression: a systematic umbrella review of the evidence	32
Microbiota–gut–brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities	32
Transcriptomic profiles in major depressive disorder: the role of immunometabolic and cell-cycle-related pathways in depression with different levels of inflammation	32
Mechanisms of action of fluvoxamine for COVID-19: a historical review	32
A novel circular RNA, circIgfbp2, links neural plasticity and anxiety through targeting mitochondrial dysfunction and oxidative stress-induced synapse dysfunction after traumatic brain injury	32
Neural mechanisms of emotional health in traumatic brain injury patients undergoing rTMS treatment	31
Quantitative magnetization transfer and g-ratio imaging of white matter myelin in early psychotic spectrum disorders	31
Molecular phenotypes associated with antipsychotic drugs in the human caudate nucleus	31
Genome-wide association study of traumatic brain injury in U.S. military veterans enrolled in the VA million veteran program	31
Age-related vulnerability of the human brain connectome	31
Hippocampal acetylcholine modulates stress-related behaviors independent of specific cholinergic inputs	31
Functional connectivity signatures of major depressive disorder: machine learning analysis of two multicenter neuroimaging studies	31
The role of glial autophagy in Alzheimer’s disease	31
VEGF-A in serum protects against memory impairment in APP/PS1 transgenic mice by blocking neutrophil infiltration	31
Enhancing GluN2A-type NMDA receptors impairs long-term synaptic plasticity and learning and memory	31
Transcriptomic risk scores for attention deficit/hyperactivity disorder	31
CPEB and translational control by cytoplasmic polyadenylation: impact on synaptic plasticity, learning, and memory	30
Transcriptomic dysregulation and autistic-like behaviors in Kmt2c haploinsufficient mice rescued by an LSD1 inhibitor	30
A genetics-first approach to understanding autism and schizophrenia spectrum disorders: the 22q11.2 deletion syndrome	30
Loss of mGlu5 receptors in somatostatin-expressing neurons alters negative emotional states	30
What genes are differentially expressed in individuals with schizophrenia? A systematic review	30
Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE ε2 protective effect in Alzheimer disease	30
The Alzheimer’s disease risk gene BIN1 regulates activity-dependent gene expression in human-induced glutamatergic neurons	30
Chronometric TMS-fMRI of personalized left dorsolateral prefrontal target reveals state-dependency of subgenual anterior cingulate cortex effects	30
Transcriptome and chromatin alterations in social fear indicate association of MEG3 with successful extinction of fear	29
The Southern European Atlantic diet and depression risk: a European multicohort study	29
Prefrontal, parietal, and limbic condition-dependent differences in bipolar disorder: a large-scale meta-analysis of functional neuroimaging studies	29
Human ARHGEF9 intellectual disability syndrome is phenocopied by a mutation that disrupts collybistin binding to the GABAA receptor α2 subunit	29
Both GEF domains of the autism and developmental epileptic encephalopathy-associated Trio protein are required for proper tangential migration of GABAergic interneurons	29
Mitochondrial health index correlates with plasma circulating cell-free mitochondrial DNA in bipolar disorder	29
The lncRNA Snhg11, a new candidate contributing to neurogenesis, plasticity, and memory deficits in Down syndrome	29
Shared and distinct abnormalities in sleep-wake patterns and their relationship with the negative symptoms of Schizophrenia Spectrum Disorder patients	29
Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood–brain barrier	29
Neurocognitive effects of stress: a metaparadigm perspective	29
Widespread choroid plexus contamination in sampling and profiling of brain tissue	29
Abnormal dynamic functional connectivity during fear extinction learning in PTSD and anxiety disorders	28
Angiotensin blockade enhances motivational reward learning via enhancing striatal prediction error signaling and frontostriatal communication	28
Testing the causal relationships of physical activity and sedentary behaviour with mental health and substance use disorders: a Mendelian randomisation study	28
Global and local ancestry modulate APOE association with Alzheimer’s neuropathology and cognitive outcomes in an admixed sample	28
Intrinsically dysregulated cellular stress signaling genes and gene networks in postpartum depression	28
MYT1L haploinsufficiency in human neurons and mice causes autism-associated phenotypes that can be reversed by genetic and pharmacologic intervention	28
Exploring the genetic heterogeneity in major depression across diagnostic criteria	28
Peripheral inflammation is associated with micro-structural and functional connectivity changes in depression-related brain networks	28
African ancestry GWAS of dementia in a large military cohort identifies significant risk loci	28
Activation of cell-free mtDNA-TLR9 signaling mediates chronic stress-induced social behavior deficits	28